These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 8534266)
1. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of protection of lobenzarit against paracetamol-induced toxicity in rat hepatocytes. Remirez D; Commandeur JN; Groot E; Vermeulen NP Eur J Pharmacol; 1995 Dec; 293(4):301-8. PubMed ID: 8748682 [TBL] [Abstract][Full Text] [Related]
3. Interaction of 2,4,4'-trichloro-2'-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver. Hanioka N; Omae E; Nishimura T; Jinno H; Onodera S; Yoda R; Ando M Chemosphere; 1996 Jul; 33(2):265-76. PubMed ID: 8696774 [TBL] [Abstract][Full Text] [Related]
4. Effects of bioflavonoids on hepatic P450 activities. Obermeier MT; White RE; Yang CS Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes. Dhawan A; Parmar D; Dayal M; Seth PK Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197 [TBL] [Abstract][Full Text] [Related]
6. The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Kimonen T; Juvonen RO; Alhava E; Pasanen M Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Thapliyal R; Maru GB Food Chem Toxicol; 2001 Jun; 39(6):541-7. PubMed ID: 11346483 [TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol. De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222 [TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105 [TBL] [Abstract][Full Text] [Related]
10. Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung, and kidney of untreated, phenobarbital-treated, and beta-naphthoflavone-treated guinea pigs. Knickle LC; Bend JR Can J Physiol Pharmacol; 1992 Dec; 70(12):1610-7. PubMed ID: 1301239 [TBL] [Abstract][Full Text] [Related]
11. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship study. Conaway CC; Jiao D; Chung FL Carcinogenesis; 1996 Nov; 17(11):2423-7. PubMed ID: 8968058 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes. Nakajima T; Elovaara E; Park SS; Gelboin HV; Hietanen E; Vainio H Biochem Pharmacol; 1990 Sep; 40(6):1255-61. PubMed ID: 2403379 [TBL] [Abstract][Full Text] [Related]
15. Fasting for less than 24 h induces cytochrome P450 2E1 and 2B1/2 activities in rats. Brown BL; Allis JW; Simmons JE; House DE Toxicol Lett; 1995 Nov; 81(1):39-44. PubMed ID: 8525497 [TBL] [Abstract][Full Text] [Related]
16. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of H2-receptor antagonists on cytochrome P450 in male ICR mice. Kim DH; Kim EJ; Han SS; Roh JK; Jeong TC; Park JH Hum Exp Toxicol; 1995 Aug; 14(8):623-9. PubMed ID: 7576828 [TBL] [Abstract][Full Text] [Related]
18. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes. Menicagli S; Lippi A; Criscuoli M; Gervasi PG Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039 [TBL] [Abstract][Full Text] [Related]
19. Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. Falkner KC; McCallum GP; Cherian MG; Bend JR Chem Biol Interact; 1993 Jan; 86(1):51-68. PubMed ID: 8431965 [TBL] [Abstract][Full Text] [Related]
20. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]